Dermatomyositis: factors predicting relapse
Identifieur interne : 002965 ( Istex/Corpus ); précédent : 002964; suivant : 002966Dermatomyositis: factors predicting relapse
Auteurs : V. Vuong ; T. A. Duong ; J. Aouizerate ; F. J. Authier ; S. Ingen-Housz-Oro ; L. Valeyrie-Allanore ; N. Ortonne ; P. Wolkenstein ; R. K. Gherardi ; O. Chosidow ; A. Cosnes ; E. SbidianSource :
- Journal of the European Academy of Dermatology and Venereology [ 0926-9959 ] ; 2016-05.
Abstract
Background: The course of dermatomyositis (DM) can be chronic with relapses, which are associated with major morbidity. Objective: The aim of this study was to identify presentation features that predict DM relapses. Methods: We retrospectively reviewed data of patients with DM recorded from 1990 to 2011, including muscle biopsy results. Characteristics of patients with and without relapses were compared. Hazard ratios (HRs) were estimated using a Cox model. Results: We identified 34 patients, with a mean age of 46 ± 17 years (range, 18–77) and 24 (71%) women. The muscle and skin abnormalities relapsed in 21 (61%) patients. By univariate analysis, two presentation features were significantly associated with a subsequently relapsing course, namely, dysphonia [HR = 3.2 (1.2–8.5)] and greater skin lesion severity defined as a Cutaneous Disease Area Severity Index [CDASI] > 20 [HR = 3.5 (1.2–7.9)]. Conclusion: Dysphonia and skin lesion severity at disease onset must be recorded, as they significantly predict a relapsing disease course.
Url:
DOI: 10.1111/jdv.13516
Links to Exploration step
ISTEX:38B2BB673D5B7C795A0A7DE9D9EA9D064331292ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dermatomyositis: factors predicting relapse</title><author><name sortKey="Vuong, V" sort="Vuong, V" uniqKey="Vuong V" first="V." last="Vuong">V. Vuong</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Duong, T A" sort="Duong, T A" uniqKey="Duong T" first="T. A." last="Duong">T. A. Duong</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Aouizerate, J" sort="Aouizerate, J" uniqKey="Aouizerate J" first="J." last="Aouizerate">J. Aouizerate</name><affiliation><mods:affiliation>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, INSERM U955‐Unité 10, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Authier, F J" sort="Authier, F J" uniqKey="Authier F" first="F. J." last="Authier">F. J. Authier</name><affiliation><mods:affiliation>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, INSERM U955‐Unité 10, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Ingen Ousz Ro, S" sort="Ingen Ousz Ro, S" uniqKey="Ingen Ousz Ro S" first="S." last="Ingen-Housz-Oro">S. Ingen-Housz-Oro</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Valeyrie Llanore, L" sort="Valeyrie Llanore, L" uniqKey="Valeyrie Llanore L" first="L." last="Valeyrie-Allanore">L. Valeyrie-Allanore</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Ortonne, N" sort="Ortonne, N" uniqKey="Ortonne N" first="N." last="Ortonne">N. Ortonne</name><affiliation><mods:affiliation>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Wolkenstein, P" sort="Wolkenstein, P" uniqKey="Wolkenstein P" first="P." last="Wolkenstein">P. Wolkenstein</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Gherardi, R K" sort="Gherardi, R K" uniqKey="Gherardi R" first="R. K." last="Gherardi">R. K. Gherardi</name><affiliation><mods:affiliation>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, INSERM U955‐Unité 10, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Chosidow, O" sort="Chosidow, O" uniqKey="Chosidow O" first="O." last="Chosidow">O. Chosidow</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, INSERM, CIC 1430, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Cosnes, A" sort="Cosnes, A" uniqKey="Cosnes A" first="A." last="Cosnes">A. Cosnes</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Sbidian, E" sort="Sbidian, E" uniqKey="Sbidian E" first="E." last="Sbidian">E. Sbidian</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, INSERM, CIC 1430, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: emilie.sbidian@hmn.aphp.fr</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:38B2BB673D5B7C795A0A7DE9D9EA9D064331292E</idno><date when="2016" year="2016">2016</date><idno type="doi">10.1111/jdv.13516</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-PTCJV7T9-F/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002965</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002965</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Dermatomyositis: factors predicting relapse</title><author><name sortKey="Vuong, V" sort="Vuong, V" uniqKey="Vuong V" first="V." last="Vuong">V. Vuong</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Duong, T A" sort="Duong, T A" uniqKey="Duong T" first="T. A." last="Duong">T. A. Duong</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Aouizerate, J" sort="Aouizerate, J" uniqKey="Aouizerate J" first="J." last="Aouizerate">J. Aouizerate</name><affiliation><mods:affiliation>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, INSERM U955‐Unité 10, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Authier, F J" sort="Authier, F J" uniqKey="Authier F" first="F. J." last="Authier">F. J. Authier</name><affiliation><mods:affiliation>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, INSERM U955‐Unité 10, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Ingen Ousz Ro, S" sort="Ingen Ousz Ro, S" uniqKey="Ingen Ousz Ro S" first="S." last="Ingen-Housz-Oro">S. Ingen-Housz-Oro</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Valeyrie Llanore, L" sort="Valeyrie Llanore, L" uniqKey="Valeyrie Llanore L" first="L." last="Valeyrie-Allanore">L. Valeyrie-Allanore</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Ortonne, N" sort="Ortonne, N" uniqKey="Ortonne N" first="N." last="Ortonne">N. Ortonne</name><affiliation><mods:affiliation>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Wolkenstein, P" sort="Wolkenstein, P" uniqKey="Wolkenstein P" first="P." last="Wolkenstein">P. Wolkenstein</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Gherardi, R K" sort="Gherardi, R K" uniqKey="Gherardi R" first="R. K." last="Gherardi">R. K. Gherardi</name><affiliation><mods:affiliation>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, INSERM U955‐Unité 10, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Chosidow, O" sort="Chosidow, O" uniqKey="Chosidow O" first="O." last="Chosidow">O. Chosidow</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, INSERM, CIC 1430, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Cosnes, A" sort="Cosnes, A" uniqKey="Cosnes A" first="A." last="Cosnes">A. Cosnes</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation></author><author><name sortKey="Sbidian, E" sort="Sbidian, E" uniqKey="Sbidian E" first="E." last="Sbidian">E. Sbidian</name><affiliation><mods:affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Université Paris Est, INSERM, CIC 1430, Créteil, France</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: emilie.sbidian@hmn.aphp.fr</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of the European Academy of Dermatology and Venereology</title><title level="j" type="alt">JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY</title><idno type="ISSN">0926-9959</idno><idno type="eISSN">1468-3083</idno><imprint><biblScope unit="vol">30</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="813">813</biblScope><biblScope unit="page" to="818">818</biblScope><biblScope unit="page-count">6</biblScope><date type="published" when="2016-05">2016-05</date></imprint><idno type="ISSN">0926-9959</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0926-9959</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Background: The course of dermatomyositis (DM) can be chronic with relapses, which are associated with major morbidity. Objective: The aim of this study was to identify presentation features that predict DM relapses. Methods: We retrospectively reviewed data of patients with DM recorded from 1990 to 2011, including muscle biopsy results. Characteristics of patients with and without relapses were compared. Hazard ratios (HRs) were estimated using a Cox model. Results: We identified 34 patients, with a mean age of 46 ± 17 years (range, 18–77) and 24 (71%) women. The muscle and skin abnormalities relapsed in 21 (61%) patients. By univariate analysis, two presentation features were significantly associated with a subsequently relapsing course, namely, dysphonia [HR = 3.2 (1.2–8.5)] and greater skin lesion severity defined as a Cutaneous Disease Area Severity Index [CDASI] > 20 [HR = 3.5 (1.2–7.9)]. Conclusion: Dysphonia and skin lesion severity at disease onset must be recorded, as they significantly predict a relapsing disease course.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>V. Vuong</name><affiliations><json:string>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</json:string></affiliations></json:item><json:item><name>T.A. Duong</name><affiliations><json:string>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</json:string></affiliations></json:item><json:item><name>J. Aouizerate</name><affiliations><json:string>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</json:string><json:string>Université Paris Est, IMRB, INSERM U955‐Unité 10, Créteil, France</json:string></affiliations></json:item><json:item><name>F.J. Authier</name><affiliations><json:string>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</json:string><json:string>Université Paris Est, IMRB, INSERM U955‐Unité 10, Créteil, France</json:string></affiliations></json:item><json:item><name>S. Ingen‐Housz‐Oro</name><affiliations><json:string>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</json:string><json:string>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</json:string></affiliations></json:item><json:item><name>L. Valeyrie‐Allanore</name><affiliations><json:string>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</json:string><json:string>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</json:string></affiliations></json:item><json:item><name>N. Ortonne</name><affiliations><json:string>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</json:string></affiliations></json:item><json:item><name>P. Wolkenstein</name><affiliations><json:string>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</json:string><json:string>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</json:string></affiliations></json:item><json:item><name>R.K. Gherardi</name><affiliations><json:string>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</json:string><json:string>Université Paris Est, IMRB, INSERM U955‐Unité 10, Créteil, France</json:string></affiliations></json:item><json:item><name>O. Chosidow</name><affiliations><json:string>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</json:string><json:string>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</json:string><json:string>Université Paris Est, INSERM, CIC 1430, Créteil, France</json:string></affiliations></json:item><json:item><name>A. Cosnes</name><affiliations><json:string>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</json:string></affiliations></json:item><json:item><name>E. Sbidian</name><affiliations><json:string>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</json:string><json:string>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</json:string><json:string>Université Paris Est, INSERM, CIC 1430, Créteil, France</json:string><json:string>E-mail: emilie.sbidian@hmn.aphp.fr</json:string></affiliations></json:item></author><articleId><json:string>JDV13516</json:string></articleId><arkIstex>ark:/67375/WNG-PTCJV7T9-F</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>Background: The course of dermatomyositis (DM) can be chronic with relapses, which are associated with major morbidity. Objective: The aim of this study was to identify presentation features that predict DM relapses. Methods: We retrospectively reviewed data of patients with DM recorded from 1990 to 2011, including muscle biopsy results. Characteristics of patients with and without relapses were compared. Hazard ratios (HRs) were estimated using a Cox model. Results: We identified 34 patients, with a mean age of 46 ± 17 years (range, 18–77) and 24 (71%) women. The muscle and skin abnormalities relapsed in 21 (61%) patients. By univariate analysis, two presentation features were significantly associated with a subsequently relapsing course, namely, dysphonia [HR = 3.2 (1.2–8.5)] and greater skin lesion severity defined as a Cutaneous Disease Area Severity Index [CDASI] > 20 [HR = 3.5 (1.2–7.9)]. Conclusion: Dysphonia and skin lesion severity at disease onset must be recorded, as they significantly predict a relapsing disease course.</abstract><qualityIndicators><score>7.276</score><pdfWordCount>3380</pdfWordCount><pdfCharCount>22243</pdfCharCount><pdfVersion>1.6</pdfVersion><pdfPageCount>6</pdfPageCount><pdfPageSize>595.276 x 782.362 pts</pdfPageSize><pdfWordsPerPage>563</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>158</abstractWordCount><abstractCharCount>1047</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Dermatomyositis: factors predicting relapse</title><genre><json:string>article</json:string></genre><host><title>Journal of the European Academy of Dermatology and Venereology</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1468-3083</json:string></doi><issn><json:string>0926-9959</json:string></issn><eissn><json:string>1468-3083</json:string></eissn><publisherId><json:string>JDV</json:string></publisherId><volume>30</volume><issue>5</issue><pages><first>813</first><last>818</last><total>6</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Original Article</value></json:item><json:item><value>ORIGINAL ARTICLES AND SHORT REPORTS</value></json:item><json:item><value>PSORIASIS AND AUTOIMMUNE DISEASES</value></json:item></subject></host><ark><json:string>ark:/67375/WNG-PTCJV7T9-F</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - dermatology</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - dermatology & venereal diseases</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Infectious Diseases</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Dermatology</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2016</publicationDate><copyrightDate>2016</copyrightDate><doi><json:string>10.1111/jdv.13516</json:string></doi><id>38B2BB673D5B7C795A0A7DE9D9EA9D064331292E</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-PTCJV7T9-F/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-PTCJV7T9-F/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-PTCJV7T9-F/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Dermatomyositis: factors predicting relapse</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-QW5Q88H5-V">Wiley Publishing Ltd</publisher><availability><licence>© 2015 European Academy of Dermatology and Venereology</licence></availability><date type="published" when="2016-05"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Dermatomyositis: factors predicting relapse</title><author xml:id="author-0000"><persName><forename type="first">V.</forename><surname>Vuong</surname></persName><affiliation><orgName type="division">AP‐HP</orgName>
<orgName type="division">DHU‐VIC</orgName>
<orgName type="division">Service de Dermatologie</orgName>
<orgName type="institution">Hôpitaux universitaires Henri Mondor</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">T.A.</forename><surname>Duong</surname></persName><affiliation><orgName type="division">AP‐HP</orgName>
<orgName type="division">DHU‐VIC</orgName>
<orgName type="division">Service de Dermatologie</orgName>
<orgName type="institution">Hôpitaux universitaires Henri Mondor</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">J.</forename><surname>Aouizerate</surname></persName><affiliation><orgName type="division">AP‐HP</orgName>
<orgName type="division">Département de Pathologie</orgName>
<orgName type="division">Centre de référence des pathologies neuromusculaires</orgName>
<orgName type="institution">Hôpitaux universitaires Henri Mondor</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation><affiliation><orgName type="institution">Université Paris Est</orgName>
<orgName type="institution">IMRB</orgName>
<orgName type="institution">INSERM U955‐Unité 10</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">F.J.</forename><surname>Authier</surname></persName><affiliation><orgName type="division">AP‐HP</orgName>
<orgName type="division">Département de Pathologie</orgName>
<orgName type="division">Centre de référence des pathologies neuromusculaires</orgName>
<orgName type="institution">Hôpitaux universitaires Henri Mondor</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation><affiliation><orgName type="institution">Université Paris Est</orgName>
<orgName type="institution">IMRB</orgName>
<orgName type="institution">INSERM U955‐Unité 10</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0004"><persName><forename type="first">S.</forename><surname>Ingen‐Housz‐Oro</surname></persName><affiliation><orgName type="division">AP‐HP</orgName>
<orgName type="division">DHU‐VIC</orgName>
<orgName type="division">Service de Dermatologie</orgName>
<orgName type="institution">Hôpitaux universitaires Henri Mondor</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation><affiliation><orgName type="institution">Université Paris Est</orgName>
<orgName type="institution">IMRB</orgName>
<orgName type="institution">EA 7379 EpiDermE</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0005"><persName><forename type="first">L.</forename><surname>Valeyrie‐Allanore</surname></persName><affiliation><orgName type="division">AP‐HP</orgName>
<orgName type="division">DHU‐VIC</orgName>
<orgName type="division">Service de Dermatologie</orgName>
<orgName type="institution">Hôpitaux universitaires Henri Mondor</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation><affiliation><orgName type="institution">Université Paris Est</orgName>
<orgName type="institution">IMRB</orgName>
<orgName type="institution">EA 7379 EpiDermE</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0006"><persName><forename type="first">N.</forename><surname>Ortonne</surname></persName><affiliation><orgName type="division">AP‐HP</orgName>
<orgName type="division">Département de Pathologie</orgName>
<orgName type="division">Centre de référence des pathologies neuromusculaires</orgName>
<orgName type="institution">Hôpitaux universitaires Henri Mondor</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0007"><persName><forename type="first">P.</forename><surname>Wolkenstein</surname></persName><affiliation><orgName type="division">AP‐HP</orgName>
<orgName type="division">DHU‐VIC</orgName>
<orgName type="division">Service de Dermatologie</orgName>
<orgName type="institution">Hôpitaux universitaires Henri Mondor</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation><affiliation><orgName type="institution">Université Paris Est</orgName>
<orgName type="institution">IMRB</orgName>
<orgName type="institution">EA 7379 EpiDermE</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0008"><persName><forename type="first">R.K.</forename><surname>Gherardi</surname></persName><affiliation><orgName type="division">AP‐HP</orgName>
<orgName type="division">Département de Pathologie</orgName>
<orgName type="division">Centre de référence des pathologies neuromusculaires</orgName>
<orgName type="institution">Hôpitaux universitaires Henri Mondor</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation><affiliation><orgName type="institution">Université Paris Est</orgName>
<orgName type="institution">IMRB</orgName>
<orgName type="institution">INSERM U955‐Unité 10</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0009"><persName><forename type="first">O.</forename><surname>Chosidow</surname></persName><affiliation><orgName type="division">AP‐HP</orgName>
<orgName type="division">DHU‐VIC</orgName>
<orgName type="division">Service de Dermatologie</orgName>
<orgName type="institution">Hôpitaux universitaires Henri Mondor</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation><affiliation><orgName type="institution">Université Paris Est</orgName>
<orgName type="institution">IMRB</orgName>
<orgName type="institution">EA 7379 EpiDermE</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation><affiliation><orgName type="institution">Université Paris Est</orgName>
<orgName type="institution">INSERM</orgName>
<orgName type="institution">CIC 1430</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0010"><persName><forename type="first">A.</forename><surname>Cosnes</surname></persName><affiliation><orgName type="division">AP‐HP</orgName>
<orgName type="division">DHU‐VIC</orgName>
<orgName type="division">Service de Dermatologie</orgName>
<orgName type="institution">Hôpitaux universitaires Henri Mondor</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0011" role="corresp"><persName><forename type="first">E.</forename><surname>Sbidian</surname></persName><affiliation><orgName type="division">AP‐HP</orgName>
<orgName type="division">DHU‐VIC</orgName>
<orgName type="division">Service de Dermatologie</orgName>
<orgName type="institution">Hôpitaux universitaires Henri Mondor</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation><affiliation><orgName type="institution">Université Paris Est</orgName>
<orgName type="institution">IMRB</orgName>
<orgName type="institution">EA 7379 EpiDermE</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation><affiliation><orgName type="institution">Université Paris Est</orgName>
<orgName type="institution">INSERM</orgName>
<orgName type="institution">CIC 1430</orgName>
<address><settlement>Créteil</settlement>
<country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><idno type="istex">38B2BB673D5B7C795A0A7DE9D9EA9D064331292E</idno><idno type="ark">ark:/67375/WNG-PTCJV7T9-F</idno><idno type="DOI">10.1111/jdv.13516</idno><idno type="unit">JDV13516</idno><idno type="toTypesetVersion">file:JDV.JDV13516.pdf</idno></analytic><monogr><title level="j" type="main">Journal of the European Academy of Dermatology and Venereology</title><title level="j" type="alt">JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY</title><idno type="pISSN">0926-9959</idno><idno type="eISSN">1468-3083</idno><idno type="book-DOI">10.1111/(ISSN)1468-3083</idno><idno type="book-part-DOI">10.1111/jdv.2016.30.issue-5</idno><idno type="product">JDV</idno><imprint><biblScope unit="vol">30</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="813">813</biblScope><biblScope unit="page" to="818">818</biblScope><biblScope unit="page-count">6</biblScope><date type="published" when="2016-05"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract style="main" xml:id="jdv13516-abs-0001"><head>Abstract</head><head>Background</head><p>The course of dermatomyositis (<hi rend="fc">DM</hi>) can be chronic with relapses, which are associated with major morbidity.</p><head>Objective</head><p>The aim of this study was to identify presentation features that predict <hi rend="fc">DM</hi> relapses.</p><head>Methods</head><p>We retrospectively reviewed data of patients with <hi rend="fc">DM</hi> recorded from 1990 to 2011, including muscle biopsy results. Characteristics of patients with and without relapses were compared. Hazard ratios (<hi rend="fc">HR</hi>s) were estimated using a Cox model.</p><head>Results</head><p>We identified 34 patients, with a mean age of 46 ± 17 years (range, 18–77) and 24 (71%) women. The muscle and skin abnormalities relapsed in 21 (61%) patients. By univariate analysis, two presentation features were significantly associated with a subsequently relapsing course, namely, dysphonia [<hi rend="fc">HR</hi> = 3.2 (1.2–8.5)] and greater skin lesion severity defined as a Cutaneous Disease Area Severity Index [<hi rend="fc">CDASI</hi>] > 20 [<hi rend="fc">HR</hi> = 3.5 (1.2–7.9)].</p><head>Conclusion</head><p>Dysphonia and skin lesion severity at disease onset must be recorded, as they significantly predict a relapsing disease course.</p></abstract><textClass><keywords rend="articleCategory"><term>Original Article</term></keywords><keywords rend="tocHeading1"><term>ORIGINAL ARTICLES AND SHORT REPORTS</term></keywords><keywords rend="tocHeading2"><term>PSORIASIS AND AUTOIMMUNE DISEASES</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-PTCJV7T9-F/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component type="serialArticle" version="2.0" xml:id="jdv13516" xml:lang="en"><header><publicationMeta level="product"><doi origin="wiley" registered="yes">10.1111/(ISSN)1468-3083</doi><issn type="print">0926-9959</issn><issn type="electronic">1468-3083</issn><idGroup><id type="product" value="JDV"></id></idGroup><titleGroup><title sort="JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY" type="main">Journal of the European Academy of Dermatology and Venereology</title><title type="short">J Eur Acad Dermatol Venereol</title></titleGroup></publicationMeta><publicationMeta level="part" position="50"><doi origin="wiley">10.1111/jdv.2016.30.issue-5</doi><copyright ownership="thirdParty">Copyright © 2016 European Academy of Dermatology and Venereology</copyright><numberingGroup><numbering number="30" type="journalVolume">30</numbering><numbering type="journalIssue">5</numbering></numberingGroup><coverDate startDate="2016-05">May 2016</coverDate></publicationMeta><publicationMeta level="unit" position="130" status="forIssue" type="article"><doi>10.1111/jdv.13516</doi><idGroup><id type="unit" value="JDV13516"></id></idGroup><countGroup><count number="6" type="pageTotal"></count></countGroup><titleGroup><title type="articleCategory">Original Article</title><title type="tocHeading1">ORIGINAL ARTICLES AND SHORT REPORTS</title><title type="tocHeading2">PSORIASIS AND AUTOIMMUNE DISEASES</title></titleGroup><copyright ownership="thirdParty">© 2015 European Academy of Dermatology and Venereology</copyright><eventGroup><event date="2015-06-08" type="manuscriptReceived"></event><event date="2015-10-02" type="manuscriptAccepted"></event><event agent="SPS" date="2015-11-03" type="xmlCreated"></event><event type="firstOnline" date="2015-12-15"></event><event type="publishedOnlineEarlyUnpaginated" date="2015-12-15"></event><event type="publishedOnlineFinalForm" date="2016-04-13"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:5.0.6 mode:FullText" date="2017-02-10"></event></eventGroup><numberingGroup><numbering type="pageFirst">813</numbering><numbering type="pageLast">818</numbering></numberingGroup><correspondenceTo>Correspondence: E. Sbidian. E‐mail: <email>emilie.sbidian@hmn.aphp.fr</email></correspondenceTo><attributeValueGroup><attributeValue attribute="type" element="note" value="equal"></attributeValue></attributeValueGroup><linkGroup><link type="toTypesetVersion" href="file:JDV.JDV13516.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Dermatomyositis: factors predicting relapse</title><title type="shortAuthors">Vuong <i>et al</i>.</title></titleGroup><creators><creator affiliationRef="#jdv13516-aff-0001" creatorRole="author" xml:id="jdv13516-cr-0001"><personName><givenNames>V.</givenNames> <familyName>Vuong</familyName></personName></creator><creator affiliationRef="#jdv13516-aff-0001" creatorRole="author" xml:id="jdv13516-cr-0002"><personName><givenNames>T.A.</givenNames> <familyName>Duong</familyName></personName></creator><creator affiliationRef="#jdv13516-aff-0002 #jdv13516-aff-0003" creatorRole="author" xml:id="jdv13516-cr-0003"><personName><givenNames>J.</givenNames> <familyName>Aouizerate</familyName></personName></creator><creator affiliationRef="#jdv13516-aff-0002 #jdv13516-aff-0003" creatorRole="author" xml:id="jdv13516-cr-0004"><personName><givenNames>F.J.</givenNames> <familyName>Authier</familyName></personName></creator><creator affiliationRef="#jdv13516-aff-0001 #jdv13516-aff-0004" creatorRole="author" xml:id="jdv13516-cr-0005"><personName><givenNames>S.</givenNames> <familyName>Ingen‐Housz‐Oro</familyName></personName></creator><creator affiliationRef="#jdv13516-aff-0001 #jdv13516-aff-0004" creatorRole="author" xml:id="jdv13516-cr-0006"><personName><givenNames>L.</givenNames> <familyName>Valeyrie‐Allanore</familyName></personName></creator><creator affiliationRef="#jdv13516-aff-0002" creatorRole="author" xml:id="jdv13516-cr-0007"><personName><givenNames>N.</givenNames> <familyName>Ortonne</familyName></personName></creator><creator affiliationRef="#jdv13516-aff-0001 #jdv13516-aff-0004" noteRef="#jdv13516-note-0003" creatorRole="author" xml:id="jdv13516-cr-0008"><personName><givenNames>P.</givenNames> <familyName>Wolkenstein</familyName></personName></creator><creator affiliationRef="#jdv13516-aff-0002 #jdv13516-aff-0003" creatorRole="author" noteRef="#jdv13516-note-0003" xml:id="jdv13516-cr-0009"><personName><givenNames>R.K.</givenNames> <familyName>Gherardi</familyName></personName></creator><creator affiliationRef="#jdv13516-aff-0001 #jdv13516-aff-0004 #jdv13516-aff-0005" creatorRole="author" noteRef="#jdv13516-note-0003" xml:id="jdv13516-cr-0010"><personName><givenNames>O.</givenNames> <familyName>Chosidow</familyName></personName></creator><creator affiliationRef="#jdv13516-aff-0001" creatorRole="author" noteRef="#jdv13516-note-0003" xml:id="jdv13516-cr-0011"><personName><givenNames>A.</givenNames> <familyName>Cosnes</familyName></personName></creator><creator affiliationRef="#jdv13516-aff-0001 #jdv13516-aff-0004 #jdv13516-aff-0005" corresponding="yes" creatorRole="author" xml:id="jdv13516-cr-0012"><personName><givenNames>E.</givenNames> <familyName>Sbidian</familyName></personName></creator></creators><affiliationGroup><affiliation countryCode="FR" type="organization" xml:id="jdv13516-aff-0001"><orgDiv>AP‐HP</orgDiv> <orgDiv>DHU‐VIC</orgDiv> <orgDiv>Service de Dermatologie</orgDiv> <orgName>Hôpitaux universitaires Henri Mondor</orgName> <address><city>Créteil</city> <country>France</country></address></affiliation><affiliation countryCode="FR" type="organization" xml:id="jdv13516-aff-0002"><orgDiv>AP‐HP</orgDiv> <orgDiv>Département de Pathologie</orgDiv> <orgDiv>Centre de référence des pathologies neuromusculaires</orgDiv> <orgName>Hôpitaux universitaires Henri Mondor</orgName> <address><city>Créteil</city> <country>France</country></address></affiliation><affiliation countryCode="FR" type="organization" xml:id="jdv13516-aff-0003"><orgName>Université Paris Est</orgName> <orgName>IMRB</orgName> <orgName>INSERM U955‐Unité 10</orgName> <address><city>Créteil</city> <country>France</country></address></affiliation><affiliation countryCode="FR" type="organization" xml:id="jdv13516-aff-0004"><orgName>Université Paris Est</orgName> <orgName>IMRB</orgName> <orgName>EA 7379 EpiDermE</orgName> <address><city>Créteil</city> <country>France</country></address></affiliation><affiliation countryCode="FR" type="organization" xml:id="jdv13516-aff-0005"><orgName>Université Paris Est</orgName> <orgName>INSERM</orgName> <orgName>CIC 1430</orgName> <address><city>Créteil</city> <country>France</country></address></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:id="jdv13516-abs-0001"><title type="main">Abstract</title><section xml:id="jdv13516-sec-0001"><title type="main">Background</title><p>The course of dermatomyositis (<fc>DM</fc>) can be chronic with relapses, which are associated with major morbidity.</p></section><section xml:id="jdv13516-sec-0002"><title type="main">Objective</title><p>The aim of this study was to identify presentation features that predict <fc>DM</fc> relapses.</p></section><section xml:id="jdv13516-sec-0003"><title type="main">Methods</title><p>We retrospectively reviewed data of patients with <fc>DM</fc> recorded from 1990 to 2011, including muscle biopsy results. Characteristics of patients with and without relapses were compared. Hazard ratios (<fc>HR</fc>s) were estimated using a Cox model.</p></section><section xml:id="jdv13516-sec-0004"><title type="main">Results</title><p>We identified 34 patients, with a mean age of 46 ± 17 years (range, 18–77) and 24 (71%) women. The muscle and skin abnormalities relapsed in 21 (61%) patients. By univariate analysis, two presentation features were significantly associated with a subsequently relapsing course, namely, dysphonia [<fc>HR</fc> = 3.2 (1.2–8.5)] and greater skin lesion severity defined as a Cutaneous Disease Area Severity Index [<fc>CDASI</fc>] > 20 [<fc>HR</fc> = 3.5 (1.2–7.9)].</p></section><section xml:id="jdv13516-sec-0005"><title type="main">Conclusion</title><p>Dysphonia and skin lesion severity at disease onset must be recorded, as they significantly predict a relapsing disease course.</p></section></abstract></abstractGroup></contentMeta><noteGroup xml:id="jdv13516-ntgp-0001"><note numbered="no" xml:id="jdv13516-note-0001"><p>Conflicts of interest</p><p>None.</p></note><note type="equal" xml:id="jdv13516-note-0002"><p>Funding source</p><p>None.</p></note><note xml:id="jdv13516-note-0003">Equal contributors.</note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Dermatomyositis: factors predicting relapse</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Dermatomyositis: factors predicting relapse</title></titleInfo><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Vuong</namePart><affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.A.</namePart><namePart type="family">Duong</namePart><affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Aouizerate</namePart><affiliation>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</affiliation><affiliation>Université Paris Est, IMRB, INSERM U955‐Unité 10, Créteil, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.J.</namePart><namePart type="family">Authier</namePart><affiliation>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</affiliation><affiliation>Université Paris Est, IMRB, INSERM U955‐Unité 10, Créteil, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Ingen‐Housz‐Oro</namePart><affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</affiliation><affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Valeyrie‐Allanore</namePart><affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</affiliation><affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N.</namePart><namePart type="family">Ortonne</namePart><affiliation>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Wolkenstein</namePart><affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</affiliation><affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</affiliation><description>Equal contributors.</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.K.</namePart><namePart type="family">Gherardi</namePart><affiliation>AP‐HP, Département de Pathologie, Centre de référence des pathologies neuromusculaires, Hôpitaux universitaires Henri Mondor, Créteil, France</affiliation><affiliation>Université Paris Est, IMRB, INSERM U955‐Unité 10, Créteil, France</affiliation><description>Equal contributors.</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Chosidow</namePart><affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</affiliation><affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</affiliation><affiliation>Université Paris Est, INSERM, CIC 1430, Créteil, France</affiliation><description>Equal contributors.</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Cosnes</namePart><affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</affiliation><description>Equal contributors.</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Sbidian</namePart><affiliation>AP‐HP, DHU‐VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France</affiliation><affiliation>Université Paris Est, IMRB, EA 7379 EpiDermE, Créteil, France</affiliation><affiliation>Université Paris Est, INSERM, CIC 1430, Créteil, France</affiliation><affiliation>E-mail: emilie.sbidian@hmn.aphp.fr</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><dateIssued encoding="w3cdtf">2016-05</dateIssued><dateCreated encoding="w3cdtf">2015-11-03</dateCreated><dateCaptured encoding="w3cdtf">2015-06-08</dateCaptured><dateValid encoding="w3cdtf">2015-10-02</dateValid><copyrightDate encoding="w3cdtf">2016</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract>Background: The course of dermatomyositis (DM) can be chronic with relapses, which are associated with major morbidity. Objective: The aim of this study was to identify presentation features that predict DM relapses. Methods: We retrospectively reviewed data of patients with DM recorded from 1990 to 2011, including muscle biopsy results. Characteristics of patients with and without relapses were compared. Hazard ratios (HRs) were estimated using a Cox model. Results: We identified 34 patients, with a mean age of 46 ± 17 years (range, 18–77) and 24 (71%) women. The muscle and skin abnormalities relapsed in 21 (61%) patients. By univariate analysis, two presentation features were significantly associated with a subsequently relapsing course, namely, dysphonia [HR = 3.2 (1.2–8.5)] and greater skin lesion severity defined as a Cutaneous Disease Area Severity Index [CDASI] > 20 [HR = 3.5 (1.2–7.9)]. Conclusion: Dysphonia and skin lesion severity at disease onset must be recorded, as they significantly predict a relapsing disease course.</abstract><relatedItem type="host"><titleInfo><title>Journal of the European Academy of Dermatology and Venereology</title></titleInfo><titleInfo type="abbreviated"><title>J Eur Acad Dermatol Venereol</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>Original Article</topic><topic>ORIGINAL ARTICLES AND SHORT REPORTS</topic><topic>PSORIASIS AND AUTOIMMUNE DISEASES</topic></subject><identifier type="ISSN">0926-9959</identifier><identifier type="eISSN">1468-3083</identifier><identifier type="DOI">10.1111/(ISSN)1468-3083</identifier><identifier type="PublisherID">JDV</identifier><part><date>2016</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><detail type="issue"><caption>no.</caption><number>5</number></detail><extent unit="pages"><start>813</start><end>818</end><total>6</total></extent></part></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0001"><titleInfo><title>Dermatomyositis</title></titleInfo><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Callen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Callen JP. Dermatomyositis. Lancet 2000; 355: 53–57.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>355</number></detail><extent unit="pages"><start>53</start><end>57</end></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>355</number></detail><extent unit="pages"><start>53</start><end>57</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0002"><titleInfo><title>Polymyositis and dermatomyositis (first of two parts)</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Bohan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JB</namePart><namePart type="family">Peter</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344–347.</note><part><date>1975</date><detail type="volume"><caption>vol.</caption><number>292</number></detail><extent unit="pages"><start>344</start><end>347</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>1975</date><detail type="volume"><caption>vol.</caption><number>292</number></detail><extent unit="pages"><start>344</start><end>347</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0003"><titleInfo><title>Polymyositis and dermatomyositis (second of two parts)</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Bohan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JB</namePart><namePart type="family">Peter</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403–407.</note><part><date>1975</date><detail type="volume"><caption>vol.</caption><number>292</number></detail><extent unit="pages"><start>403</start><end>407</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>1975</date><detail type="volume"><caption>vol.</caption><number>292</number></detail><extent unit="pages"><start>403</start><end>407</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0004"><titleInfo><title>Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis</title></titleInfo><name type="personal"><namePart type="given">I</namePart><namePart type="family">Marie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Hachulla</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PY</namePart><namePart type="family">Hatron</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Marie I, Hachulla E, Hatron PY et al. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 2001; 28: 2230–2237.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>2230</start><end>2237</end></extent></part><relatedItem type="host"><titleInfo><title>J Rheumatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>2230</start><end>2237</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0005"><titleInfo><title>National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary—Clinical characteristics and disease course of 44 patients with juvenile dermatomyositis</title></titleInfo><name type="personal"><namePart type="given">T</namePart><namePart type="family">Constantin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AT</namePart><namePart type="family">Ponyi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Ponyi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Constantin T, Ponyi AT, Ponyi A et al. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary—Clinical characteristics and disease course of 44 patients with juvenile dermatomyositis. Autoimmunity 2006; 39: 223–232.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>223</start><end>232</end></extent></part><relatedItem type="host"><titleInfo><title>Autoimmunity</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>223</start><end>232</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0006"><titleInfo><title>119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10‐12 October 2003, Naarden, The Netherlands</title></titleInfo><name type="personal"><namePart type="given">JE</namePart><namePart type="family">Hoogendijk</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AA</namePart><namePart type="family">Amato</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BR</namePart><namePart type="family">Lecky</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hoogendijk JE, Amato AA, Lecky BR et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10‐12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004; 14: 337–345.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>337</start><end>345</end></extent></part><relatedItem type="host"><titleInfo><title>Neuromuscul Disord</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>337</start><end>345</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0007"><titleInfo><title>Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Ponyi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Constantin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Balogh</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ponyi A, Constantin T, Balogh Z et al. Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis. Clin Exp Rheumatol 2005; 23: 50–56.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>50</start><end>56</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Rheumatol</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>50</start><end>56</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0008"><titleInfo><title>Long‐term outcome in polymyositis and dermatomyositis</title></titleInfo><name type="personal"><namePart type="given">IM</namePart><namePart type="family">Bronner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MFG</namePart><namePart type="family">van der Meulen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">de Visser</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bronner IM, van der Meulen MFG, de Visser M et al. Long‐term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 2006; 65: 1456–1461.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>1456</start><end>1461</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Rheum Dis</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>1456</start><end>1461</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0009"><titleInfo><title>Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Fardet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Dupuy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Gain</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fardet L, Dupuy A, Gain M et al. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore) 2009; 88: 91–97.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>91</start><end>97</end></extent></part><relatedItem type="host"><titleInfo><title>Medicine (Baltimore)</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>91</start><end>97</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0010"><titleInfo><title>Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Yassaee</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Fiorentino</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Okawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yassaee M, Fiorentino D, Okawa J et al. Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument. Br J Dermatol 2010; 162: 669–673.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>162</number></detail><extent unit="pages"><start>669</start><end>673</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>162</number></detail><extent unit="pages"><start>669</start><end>673</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0011"><titleInfo><title>International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials</title></titleInfo><name type="personal"><namePart type="given">LR</namePart><namePart type="family">Wedderburn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NJ</namePart><namePart type="family">McHugh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Chinoy</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wedderburn LR, McHugh NJ, Chinoy H et al. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum 2007; 57: 1192–1201.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1192</start><end>1201</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis Rheum</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1192</start><end>1201</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0012"><titleInfo><title>Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Varsani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SC</namePart><namePart type="family">Charman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CK</namePart><namePart type="family">Li</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Varsani H, Charman SC, Li CK et al. Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. Ann Rheum Dis 2015; 74: 204–210.</note><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>74</number></detail><extent unit="pages"><start>204</start><end>210</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Rheum Dis</title></titleInfo><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>74</number></detail><extent unit="pages"><start>204</start><end>210</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0013"><titleInfo><title>A systematic review of adult‐onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Gerami</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Scope</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">McDonald</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gerami P, Scope JM, McDonald L et al. A systematic review of adult‐onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 2006; 54: 597–613.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>54</number></detail><extent unit="pages"><start>597</start><end>613</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>54</number></detail><extent unit="pages"><start>597</start><end>613</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0014"><titleInfo><title>Frequency of relapses in patients with polymyositis and dermatomyositis</title></titleInfo><name type="personal"><namePart type="given">BA</namePart><namePart type="family">Phillips</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Zilko</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Garlepp</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Phillips BA, Zilko P, Garlepp MJ et al. Frequency of relapses in patients with polymyositis and dermatomyositis. Muscle Nerve 1998; 21: 1668–1672.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1668</start><end>1672</end></extent></part><relatedItem type="host"><titleInfo><title>Muscle Nerve</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1668</start><end>1672</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0015"><titleInfo><title>Long‐term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Ravelli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Trail</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Ferrari</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ravelli A, Trail L, Ferrari C et al. Long‐term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res 2010; 62: 63–72.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>63</start><end>72</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis Care Res</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>63</start><end>72</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0016"><titleInfo><title>Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Basset‐Seguin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JC</namePart><namePart type="family">Roujeau</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Gherardi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Basset‐Seguin N, Roujeau JC, Gherardi R et al. Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases. Arch Dermatol 1990; 126: 633–637.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>633</start><end>637</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>633</start><end>637</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0017"><titleInfo><title>Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Stringer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Singh‐Grewal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BM</namePart><namePart type="family">Feldman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Stringer E, Singh‐Grewal D, Feldman BM. Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis Rheum 2008; 58: 3585–3592.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>3585</start><end>3592</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis Rheum</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>3585</start><end>3592</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0018"><titleInfo><title>Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Miles</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KE</namePart><namePart type="family">Bove</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Lovell</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Miles L, Bove KE, Lovell D et al. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients. Arthritis Rheum 2007; 57: 1183–1191.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1183</start><end>1191</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis Rheum</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1183</start><end>1191</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13516-cit-0019"><titleInfo><title>Prognosis and mortality of polymyositis and dermatomyositis patients</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Airio</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Kautiainen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Hakala</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Airio A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 2006; 25: 234–239.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>234</start><end>239</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Rheumatol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>234</start><end>239</end></extent></part></relatedItem></relatedItem><identifier type="istex">38B2BB673D5B7C795A0A7DE9D9EA9D064331292E</identifier><identifier type="ark">ark:/67375/WNG-PTCJV7T9-F</identifier><identifier type="DOI">10.1111/jdv.13516</identifier><identifier type="ArticleID">JDV13516</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2016 European Academy of Dermatology and Venereology© 2015 European Academy of Dermatology and Venereology</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-15</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-PTCJV7T9-F/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002965 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002965 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:38B2BB673D5B7C795A0A7DE9D9EA9D064331292E
|texte= Dermatomyositis: factors predicting relapse
}}
| This area was generated with Dilib version V0.6.33. |  |